Published in J Biol Chem on May 27, 1994
A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res (1998) 3.20
gamma-Glutamyl transpeptidase. What does the organization and expression of a multipromoter gene tell us about its functions? Am J Pathol (1995) 1.25
Gamma-glutamyl transpeptidase: redox regulation and drug resistance. Adv Cancer Res (2014) 0.88
A specific distal promoter controls gamma-glutamyl transpeptidase gene expression in undifferentiated rat transformed liver cells. Biochem J (1997) 0.83
Differential expression of the rat gamma-glutamyl transpeptidase gene promoters along with differentiation of hepatoblasts into biliary or hepatocytic lineage. Am J Pathol (2000) 0.83
Three alternative promoters of the rat gamma-glutamyl transferase gene are active in developing lung and are differentially regulated by oxygen after birth. J Clin Invest (1996) 0.82
The gamma-glutamyl transpeptidase gene is transcribed from a different promoter in rat hepatocytes and biliary cells. Am J Pathol (1998) 0.79
Nucleotide sequence of bacteriophage fd DNA. Nucleic Acids Res (1978) 7.25
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet (1994) 7.07
Studies on bacteriophage fd DNA. IV. The sequence of messenger RNA for the major coat protein gene. J Mol Biol (1977) 5.34
Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol (1999) 4.70
Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem (1996) 4.50
Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem (1997) 4.12
Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem (1995) 3.45
Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem (1996) 3.05
Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem (1996) 2.95
Sequence of promoter for coat protein gene of bacteriophage fd. Nature (1976) 2.82
Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci U S A (1996) 2.68
A multistep damage recognition mechanism for global genomic nucleotide excision repair. Genes Dev (2001) 2.59
Characterization of long terminal repeat sequences of HTLV-III. Science (1985) 2.56
Uterine sutures at prior caesarean section and placenta accreta in subsequent pregnancy: a case-control study. BJOG (2014) 2.56
Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. Immunity (2000) 2.47
Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett (1998) 2.40
Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem (1997) 2.34
Oxidoreductive regulation of nuclear factor kappa B. Involvement of a cellular reducing catalyst thioredoxin. J Biol Chem (1993) 2.14
Demonstration of virus-specific transcriptional activator(s) in cells infected with HTLV-III by an in vitro cell-free system. Cell (1986) 2.13
Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o) Nature (1993) 2.08
Mass transport of proform of a KDEL-tailed cysteine proteinase (SH-EP) to protein storage vacuoles by endoplasmic reticulum-derived vesicle is involved in protein mobilization in germinating seeds. J Cell Biol (2000) 1.79
Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the golgi complex. J Biol Chem (1999) 1.79
Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res (2000) 1.69
Acute promyelocytic leukemia with marrow fibrosis at initial presentation: possible involvement of transforming growth factor-beta(1). Acta Haematol (2000) 1.66
Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2000) 1.64
Self-regeneration of a Pd-perovskite catalyst for automotive emissions control. Nature (2002) 1.58
The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem Biophys Res Commun (1998) 1.55
Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proc Natl Acad Sci U S A (1991) 1.55
Noncommutative field theory and Lorentz violation. Phys Rev Lett (2001) 1.54
Molecular cloning and nucleotide sequence of rat kidney gamma-glutamyl transpeptidase cDNA. Proc Natl Acad Sci U S A (1986) 1.52
Levels of hepatocyte growth factor in maternal serum and amniotic fluid. Am J Obstet Gynecol (1995) 1.52
Clinical importance of n-3 fatty acid-rich diet and nutritional education for the maintenance of remission in Crohn's disease. J Gastroenterol (2000) 1.47
A second p53-related protein, p73L, with high homology to p73. Biochem Biophys Res Commun (1998) 1.47
The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts. FEBS Lett (2000) 1.46
Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy. Am J Hum Genet (1998) 1.46
TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1. Cell Death Dis (2013) 1.46
The nucleotide sequence of an RNA polymerase binding site on bacteriophage fd DNA. Nature (1975) 1.45
Valgus-extension osteotomy for advanced osteoarthritis in dysplastic hips. Results at 12 to 18 years. J Bone Joint Surg Br (1997) 1.45
Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator. J Biol Chem (2001) 1.45
Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res (1995) 1.43
[Reactions of N-aminopyridinium derivatives. 8. Reactions of N-aminopyridinium salt with aldehydes]. Yakugaku Zasshi (1967) 1.43
Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress. Mol Cell Biol (1996) 1.42
A proposed optimal health care system based on a comparative study conducted between Canada and Japan. Can J Public Health (1999) 1.40
Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J Biol Chem (1999) 1.39
Generalized peritonitis due to spontaneously perforated pyometra presenting as pneumoperitoneum: report of a case. Surg Today (2000) 1.39
Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence. Cancer Res (2000) 1.38
Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer Res (1999) 1.38
Genotype-phenotype correlation of patients with multiple endocrine neoplasia type 2 in Japan. Jpn J Clin Oncol (1998) 1.38
Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor. J Biol Chem (1999) 1.37
Tissue-specific control of alpha 2u globulin gene expression: constitutive synthesis in the submaxillary gland. Cell (1983) 1.37
Local plasmon sensor with gold colloid monolayers deposited upon glass substrates. Opt Lett (2000) 1.34
Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res (2000) 1.33
Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/beta ig-h3) that binds to collagen. Biochim Biophys Acta (1997) 1.33
Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor protein. J Biol Chem (1998) 1.30
NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. Oncogene (1999) 1.30
Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum (1999) 1.29
Analysis of thermal injury-induced insulin resistance in rodents. Implication of postreceptor mechanisms. J Biol Chem (1997) 1.29
Akt-mediated survival of oligodendrocytes induced by neuregulins. J Neurosci (2000) 1.27
Atomic structure of the GCSF-receptor complex showing a new cytokine-receptor recognition scheme. Nature (1999) 1.26
Phenotypic and molecular characterization of Lactococcus lactis from milk and plants. J Appl Microbiol (2006) 1.25
Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity. Oncogene (2009) 1.24
Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-alpha-induced production of IL-6 and IL-8 from cultured synovial fibroblasts. J Immunol (1999) 1.23
DNA regions essential for the function of a bacteriophage fd promoter. Nucleic Acids Res (1977) 1.23
Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proc Natl Acad Sci U S A (1998) 1.21
RNA polymerase binding sites of phage fd replicative form DNA. Nat New Biol (1972) 1.21
Starting nucleotide sequences of RNA synthesized on the replicative form DNA of coliphage fd. J Mol Biol (1969) 1.21
Inhibition of human immunodeficiency virus type 1 replication and cytokine production by fluoroquinoline derivatives. Mol Pharmacol (1998) 1.19
Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J Biol Chem (1991) 1.18
Molecular and cellular biology of caveolae paradoxes and plasticities. Trends Cardiovasc Med (1997) 1.18
Smad3 is acetylated by p300/CBP to regulate its transactivation activity. Oncogene (2006) 1.18
Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase. Biochem J (2000) 1.18
Inhibition of nuclear factor-kappaB-mediated transcription by association with the amino-terminal enhancer of split, a Groucho-related protein lacking WD40 repeats. J Biol Chem (2000) 1.17
G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science (1996) 1.15
Modification of deoxyribonucleic acid with reductively activated mitomycin C. Structures of modified nucleotides. Chem Pharm Bull (Tokyo) (1983) 1.15
Direct control of exocytosis by receptor-mediated activation of the heterotrimeric GTPases Gi and G(o) or by the expression of their active G alpha subunits. EMBO J (1995) 1.15
Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy. Br J Ophthalmol (2005) 1.14
Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.13
Affinity-purification and characterization of caveolins from the brain: differential expression of caveolin-1, -2, and -3 in brain endothelial and astroglial cell types. Brain Res (1998) 1.13
Mutational analysis of the functional motifs of RuvB, an AAA+ class helicase and motor protein for holliday junction branch migration. Mol Microbiol (2000) 1.12
Cotyledon cells of Vigna mungo seedlings use at least two distinct autophagic machineries for degradation of starch granules and cellular components. J Cell Biol (2001) 1.12
Loss of G(1)/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1. J Virol (2000) 1.12
Studies on bacteriophage fd DNA. III. Nucleotide sequence preceding the RNA start-site on a promoter-containing fragment. Nucleic Acids Res (1975) 1.11
Identification of a cis-regulatory element involved in accumulation of human T-cell leukemia virus type II genomic mRNA. J Virol (1988) 1.11
Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage. J Biol Chem (2001) 1.11
Elucidation of a conserved RNA stem-loop structure in the packaging signal of human immunodeficiency virus type 1. FEBS Lett (1993) 1.11
Regulation of intestinal lactase in adult hypolactasia. J Clin Invest (1992) 1.11
Growth inhibition by keratinocyte growth factor receptor of human salivary adenocarcinoma cells through induction of differentiation and apoptosis. Proc Natl Acad Sci U S A (2001) 1.10
Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia. J Intern Med (2010) 1.10
Pharmacological studies of ignavine, an aconitum alkaloid. Chem Pharm Bull (Tokyo) (1982) 1.10
Potent and selective inhibition of human immunodeficiency virus type 1 transcription by piperazinyloxoquinoline derivatives. Antimicrob Agents Chemother (1997) 1.10
Identification, sequence, and expression of an invertebrate caveolin gene family from the nematode Caenorhabditis elegans. Implications for the molecular evolution of mammalian caveolin genes. J Biol Chem (1997) 1.10
Ulcerous change decreases the accuracy of endoscopic ultrasonography diagnosis for the invasive depth of early gastric cancer. Int J Gastrointest Cancer (2006) 1.10
Mutation in the threonine synthase gene results in an over-accumulation of soluble methionine in Arabidopsis. Plant Physiol (2000) 1.10
Y box-binding protein-1 binds preferentially to single-stranded nucleic acids and exhibits 3'-->5' exonuclease activity. Nucleic Acids Res (2001) 1.09
Involvement of CD4+ T cells in the development of dextran sulfate sodium-induced experimental colitis and suppressive effect of IgG on their action. Gen Pharmacol (1998) 1.09